Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROCKWELL MEDICAL, INC.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,670 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 9,633 · Balance 23,670 F1: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 13:24 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 9,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047119 · wk-form4_1783344281.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,670 F1 · kind: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. F2 · balance_after: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. Read SEC document |
| November 18, 2025 Filed Nov 18, 2025 21:26 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 5,079 | $0.87 | $4,418.73 |
DisclosureSEC source: 0001628280-25-052908 · wk-form4_1763501178.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,372 Read SEC document |
| May 20, 2025 Filed May 21, 2025 23:08 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051714 · tm2515860-2_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,451 F1 · kind: Restricted stock units vest on May 20, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:06 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 36,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-064812 · tm2415466-3_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,451 F1 · kind: Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:12 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064627 · tm2316982-1_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,594 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:34 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069688 · tm2218111-3_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,879 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012672 · wf-form4_162439717772606.xml · derivative · entry 2 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F2 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012672 · wf-form4_162439717772606.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,879 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:39 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 34,024 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001628280-20-008125 · wf-form4_159000717234796.xml · derivative · entry 2 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,024 Underlying: Common Stock · 34,024 shares Expires 2030-05-18 F3 · derivative.exercise_date: Stock options vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:39 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008125 · wf-form4_159000717234796.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,879 F1 · kind: Restricted stock units vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 19,879 shares of common stock underlying unvested restricted stock units that based on the achievement of certain time-based milestones. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 23:27 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 22,461 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001104659-19-034649 · a4.xml · derivative · entry 2 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,461 Underlying: Common Stock · 22,461 shares Expires 2029-06-06 Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 23:27 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 19,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-034649 · a4.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,879 F1 · kind: Restricted stock units vest on June 6, 2020. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 21:57 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 39,838 | $0.00 Strike: $5.75 | $0.00 |
DisclosureSEC source: 0001140361-18-014502 · doc1.xml · derivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,838 Underlying: Common Stock · 39,838 shares Expires 2028-03-19 F1 · security: The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the "2018 Plan") at the Company's 2018 Annual Meeting of Shareholders. If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person. F1 · kind: The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the "2018 Plan") at the Company's 2018 Annual Meeting of Shareholders. If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 22:36 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Appreciation Right · Derivative | 23,000 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001209191-17-052145 · doc4.xml · derivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2027-09-05 F1 · derivative.exercise_date: This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, (c) the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic, or (d) immediately prior to a change in control. This grant can only be settled in cash. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.